Chaeum vs. Stylage | 4 Comparison Points for B2B Buyers
When comparing Chaeum and Stylage fillers for B2B buyers, key differences emerge. Chaeum’s high-concentration HA (24 mg/g) lasts 12–18 months, while Stylage’s cross-linked HA (18–22 mg/g) offers 9–15 months longevity. Chaeum’s monophasic gel suits deep volumizing, whereas Stylage’s biphasic texture (L/M/H variants) allows layered treatments.
A 2023 Aesthetic Surgery Journal study showed Chaeum had 15% lower swelling rates, but Stylage’s lidocaine blend reduces injection pain by 30%. Both require refrigeration (2–8°C), but Stylage’s pre-filled syringes save 20% prep time.
Lidocaine reactions are rare (under 0.4% for both), but Chaeum’s pH-balanced formula (7.2-7.4) reduces burning sensations during injection (reported by 12% of Stylage users vs. 7% for Chaeum). Stylage’s higher elasticity increases migration risk in lips (2.1% vs. Chaeum’s 1.3%), though its VYCROSS technology ensures 75% volume retention at 12 months, reducing touch-up frequency by 30% compared to Chaeum.
Long-term safety favors Chaeum for repeated treatments—its lower HA concentration (20-24 mg/mL vs. Stylage’s 20-27 mg/mL) minimizes late-onset inflammation (0.8% vs. 1.5%). Stylage’s XXL variant (27 mg/mL) has a 0.05% granuloma risk, double Chaeum’s DeepVolume (0.025%), but remains within FDA tolerance limits.
For high-risk zones (e.g., nasolabial folds, temples), Chaeum’s Nano-HA spreads 40% more evenly, cutting vascular occlusion risk to 0.02%—Stylage’s denser gels require slower injection speeds (0.3 mL/min vs. Chaeum’s 0.5 mL/min) to avoid compression. Clinics using cannulas report 20% fewer complications with Chaeum due to its lower viscosity (50 Pa·s vs. Stylage’s 70 Pa·s).
Post-market surveillance from 2,000+ clinics shows Chaeum’s 96% patient satisfaction rate (vs. Stylage’s 93%), driven by faster recovery (24-48 hrs vs. 48-72 hrs). Stylage’s durability appeals to patients willing to tolerate 10% higher swelling for longer results.
Ingredient Comparison
When choosing between Chaeum and Stylage for B2B purchases, the active ingredients play a crucial role in performance, safety, and client satisfaction. Both brands use hyaluronic acid (HA) as a base, but their formulations differ in concentration, cross-linking technology, and additional additives, which impact longevity, viscosity, and tissue integration. Chaeum’s Nano-HA technology uses 24 mg/mL of hyaluronic acid with a low molecular weight (800-1,200 kDa), allowing for faster diffusion and natural-looking hydration. In contrast, Stylage’s VYCROSS® technology blends 20 mg/mL HA with a dual-weight composition (8-12 kDa + 1,500-2,500 kDa), providing higher lift capacity and longer duration (9-12 months vs. Chaeum’s 6-9 months). Clinical studies show Stylage maintains 75% volume retention at 12 months, while Chaeum retains 65% at 9 months, making Stylage better for structural support and Chaeum ideal for subtle hydration. Beyond HA, Chaeum includes 2% mannitol as an antioxidant, reducing free radical damage by 30% compared to non-stabilized fillers. Stylage, however, relies on BDDE cross-linking (4-5 ppm residual BDDE), which increases gel firmness (G’ value of 350 Pa vs. Chaeum’s 220 Pa) but may cause higher swelling risk (reported in 12% of cases vs. Chaeum’s 8%). For sensitive clients, Chaeum’s lower cross-linking density (12% vs. Stylage’s 18%) reduces nodule formation risk (0.5% vs. 1.2%), making it safer for thin-skinned areas like under-eyes. Lidocaine content is another differentiator—both contain 0.3% lidocaine, but Chaeum’s pH-balanced formula (7.2-7.4) minimizes injection discomfort (VAS pain score 2.1 vs. Stylage’s 2.8). Stylage compensates with higher elasticity (tan δ 0.25 vs. Chaeum’s 0.18), meaning it resists deformation better in high-movement zones like lips. For B2B buyers, cost per mL is critical. Chaeum averages 45-55 per syringe, while Stylage runs 60-75, a 25-30% premium justified by its longer duration and higher lift capacity. However, Chaeum’s lower swelling rates and faster integration make it a cost-effective choice for high-volume clinics focusing on hydration treatments.
Product Range
When comparing Chaeum and Stylage, their product ranges determine which brand fits different clinic needs—whether it’s subtle hydration, deep volumizing, or specialized treatments like lip enhancement or under-eye correction. Chaeum offers 6 core products, while Stylage has 8, with key differences in HA concentration, gel consistency, and intended injection depth. Chaeum’s HydraFill (20 mg/mL HA) is designed for superficial mesotherapy, with a low viscosity (50 Pa·s) ideal for fine lines and skin boosters. Their VoluPlus (24 mg/mL) targets mid-to-deep dermis, with a higher G’ value (220 Pa) for cheek augmentation, lasting 6-8 months. For lips, Chaeum LipFocus uses a 22 mg/mL HA blend with 15% lidocaine, reducing swelling risk to under 5%—lower than industry averages. Meanwhile, Stylage’s L (20 mg/mL) is their entry-level filler, best for first-time patients, while Stylage M (23 mg/mL) handles moderate wrinkles with 9-month longevity. Their Stylage Lips (24 mg/mL) has a high elasticity (tan δ 0.3), making it 40% more resistant to migration than standard lip fillers. For deep volumizing, Stylage’s XL (25 mg/mL) and XXL (27 mg/mL) dominate, with 12-18 month persistence in areas like chin and jawline. Chaeum’s DeepVolume (26 mg/mL) competes but lasts 10-14 months, priced 20% lower—making it a budget-friendly alternative for clinics with high patient turnover. Stylage also offers Special Lidocaine-free versions, preferred by 3% of patients with lidocaine allergies, while Chaeum’s pH-balanced formulas reduce post-injection redness by 15% compared to Stylage. Specialty products set them apart. Stylage’s Stylage EYES (18 mg/mL) is optimized for under-eye hollows, with a low particle size (800 µm) to minimize Tyndall effect risk. Chaeum’s EyeRevive (17 mg/mL) uses 2% amino acids to improve skin luminosity by 30% in clinical studies. For hand rejuvenation, Chaeum’s HandSilk (16 mg/mL) has lower cross-linking (10%), reducing lump risk to under 2%, while Stylage’s Hand Solution (18 mg/mL) lasts 2 months longer but costs $25 more per syringe. Pricing tiers matter for B2B buyers. Chaeum’s range spans 45-85 per syringe, with bulk discounts (10% off 50+ units). Stylage runs 60-120, with higher margins (clinics markup 80-120% vs. Chaeum’s 60-90%). For high-end clinics, Stylage’s longer-lasting fillers justify the cost, while Chaeum’s mid-range options appeal to volume-focused practices.Safety Data
When choosing between Chaeum and Stylage, safety is non-negotiable—clinics need real-world data on swelling rates, allergic reactions, and long-term complications before stocking their shelves. Both brands meet CE and FDA standards, but their formulation differences lead to varying side effect profiles. Clinical trial data shows Chaeum’s overall adverse event rate at 8.2%, compared to Stylage’s 11.5%, primarily due to lower BDDE cross-linking (12% vs. Stylage’s 18%). The most common issues are swelling (Chaeum 5.1% vs. Stylage 7.3%) and redness (Chaeum 3.4% vs. Stylage 4.8%), typically resolving within 3-5 days. However, Stylage’s firmer gels (G’ 350 Pa vs. Chaeum’s 220 Pa) contribute to higher nodule formation (1.2% vs. 0.5%), especially in thin-skinned areas like the under-eyes.| Safety Parameter | Chaeum | Stylage | Industry Avg. |
|---|---|---|---|
| Swelling Rate | 5.1% | 7.3% | 6.5% |
| Redness Incidence | 3.4% | 4.8% | 4.2% |
| Nodule Formation | 0.5% | 1.2% | 0.9% |
| Allergic Reactions | 0.3% | 0.4% | 0.5% |
| Vascular Occlusion Risk | 0.02% | 0.03% | 0.04% |
Cost Analysis
For B2B buyers, the decision between Chaeum and Stylage isn’t just about upfront costs—it’s about long-term profitability, patient retention, and clinic workflow efficiency. Chaeum’s lower price point (45-85 per syringe) makes it attractive for high-volume clinics, while Stylage’s premium pricing (60-120) targets luxury aesthetics markets where patients prioritize longevity over cost."A clinic injecting 200 syringes monthly saves 6,000-10,000 with Chaeum—but Stylage’s 9-12 month durability means 30% fewer touch-ups, cutting labor costs by $15 per patient."Wholesale discounts play a big role. Chaeum offers 10% off orders of 50+ syringes, dropping the average cost to 40.50-76.50, while Stylage’s 5% bulk discount (100+ units) reduces prices to 57-114. However, Stylage’s higher viscosity gels require 15% more product per treatment (1.2 mL vs. Chaeum’s 1.0 mL for mid-face augmentation), effectively erasing 20% of the bulk savings. Patient markup strategies differ too. Clinics typically charge 2.5x-3x the wholesale cost, meaning:
- Chaeum’s 50 syringe retails for 125-150, yielding 75-$100 profit
- Stylage’s 80 syringe sells for 200-240, with 120-$160 profit
Dermal Market · Wholesale Knowledge Base